In this webinar, experts from Albumedix and Heartseed show how they were able to ease challenges enroute to commercialization and bring a potential cardiomyocyte therapy to clinical trials.
- The journey of Heartseed’s investigative cardiomyocyte therapy for heart failure patients, now in Phase I/II clinical trials
- The value albumin delivers across advanced therapy applications
- How implementing Recombumin® into a manufacturing process can help improve production and support stability
- The key benefits of using chemically defined raw materials
- And more…